• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Omicron - COVID-19 Variant (B.1.1529) a "Variant of Concern" & BA.2 sub-variant, XE

And spreads stunningly fast, as the video point out.

https://thehighwire.com/videos/pros-and-cons-of-omicron/

PROS AND CONS OF OMICRON
While legacy media and Public Health Agencies continue to stoke fear over Omicron, new data is painting a different picture of the overwhelmingly mild variant. But there’s a catch; it appears to be able to efficiently escape vaccine protection.
#Omicron #PROSNCONS
POSTED: January 7, 2022
 
Has omicron already peaked in Florida? Here’s what one doctor says
Dr. Scott Gottlieb expects cases to drop this week

Brenda Argueta, Digital Journalist
Published: January 10, 2022, 7:48 AM

ORLANDO, Fla. – As the demand for COVID-19 tests remains high, the former head of the Food and Drug Administration said things should start improving soon in Florida.

“But if you look what’s happening across the East Coast right now, in New York City, Washington, D.C., Maryland, probably Florida as well, have already peaked, maybe Delaware, Rhode Island,” said Dr. Scott Gottlieb, former FDA commissioner and a Pfizer board member. “You’re going to start to see that in the statistics this week, you’re going to start to see those curves, those epidemic curves, bend down.”

His comments echo the latest modeling from the University of Florida, which also show cases will likely peak soon since omicron spread so rapidly in the community.
...
https://www.clickorlando.com/news/l...peaked-in-florida-heres-what-one-doctor-says/

---------------------------------------------------------------------------------------------
From the link above:

COVID-19 MODELS
UPDATED PROJECTIONS FOR OMICRON WAVE IN FLORIDA


Jan. 5, 2022: UF researchers updated their model projecting how a.n omicron-driven surge may unfold in Florida over the next few weeks and months. (This version supersedes the model information published Dec. 17, 2021.
...
The main finding is that the omicron wave is estimated to peak earlier than previously reported, in mid-January.

projected_cases_220104-scenario3.png


The figure above shows the reported and modeled cases per day in Florida through May 2022. The projected winter/spring surge reflects the increased infectiousness and immune escape of the omicron variant. The black line shows past actual reported COVID-19 cases, and the yellow line shows the projected reported cases per day.

...
https://epi.ufl.edu/covid-19-resour...19-omicron-wave-projections-updated-0105.html
 
January 11, 2022
4:51 AM CST
Last Updated 7 hours ago
Africa

South African studies suggest Omicron has higher 'asymptomatic carriage'

JOHANNESBURG, Jan 11 (Reuters) -
...
In the Ubuntu study evaluating the efficacy of Moderna's (MRNA.O) COVID-19 vaccine in people living with HIV, 31% of 230 participants undergoing screening tested positive, with all 56 samples available for sequencing analysis verified to be Omicron.

"This is in stark contrast to the positivity rate pre-Omicron, which ranged from less than 1% to 2.4%," the researchers said in a statement.

In a subgroup of the Sisonke trial evaluating the efficacy of Johnson & Johnson's (JNJ.N) COVID-19 vaccine, the mean asymptomatic carriage rate rose to 16% during the Omicron period from 2.6% during the Beta and Delta outbreaks.

"The Sisonke study included 577 subjects previously vaccinated, ... with results suggesting a high carriage rate even in those known to be vaccinated," the researchers said.

They added that the "higher asymptomatic carriage rate is likely a major factor in the rapid and widespread dissemination of the variant, even among populations with high prior rates of coronavirus infection".
...
https://www.reuters.com/business/he...-has-higher-asymptomatic-carriage-2022-01-11/
 
Head of COVID response for UCSF's ER dept.: 'I have not intubated a single COVID patient during this Omicron surge'

Amy Graff,SFGATE
Jan. 10, 2022
Updated: Jan. 11, 2022 9:06 a.m.

On Saturday, in response to hospitals begging for relief from a massive staffing crisis, the California Department of Public Health announced that most hospitals and skilled nursing facilities can bring COVID-positive and exposed staff back to work without testing or quarantines. The staffers must be asymptomatic, are required to wear N95 masks and are encouraged to work with patients who are already COVID-positive as much as possible.

This news might come as a surprise to people who have been reading dire warnings about omicron and some public health officials’ pleas to cancel plans and stay home. Many public health officials have argued these measures are necessary to prevent hospitals from being overwhelmed with COVID patients. Indeed, for the past few weeks, San Francisco hospitals have been in dire straits. But it’s not because people are sick — it’s because of staffing shortages driven by overly strict state quarantine rules, the director of COVID response at UCSF's emergency department said.

After reviewing the charts of every COVID-positive patient at UCSF hospitals on Jan. 4, Dr. Jeanne Noble, an associate professor of emergency medicine at UCSF, determined that 70% of them were in the hospital for other reasons.

"The real COVID crisis that our hospitals are facing is a severe staffing shortage that is compromising the quality of our care," Noble said Friday, shortly before the policy change was announced.
...
https://www.sfgate.com/bayarea/article/COVID-San-Francisco-staff-shortage-UCSF-16758335.php
 
Effectiveness of COVID-19 vaccines against Omicron or Delta infection

Sarah A. Buchan, Hannah Chung, Kevin A. Brown, Peter C. Austin, Deshayne B. Fell, Jonathan B. Gubbay, View ORCID ProfileSharifa Nasreen, Kevin L. Schwartz, Maria E. Sundaram, Mina Tadrous, Kumanan Wilson, Sarah E. Wilson, Jeffrey C. Kwong

doi: https://doi.org/10.1101/2021.12.30.21268565

This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.

ABSTRACT

Background The incidence of SARS-CoV-2 infection, including among those who have received 2 doses of COVID-19 vaccines, has increased substantially since Omicron was first identified in the province of Ontario, Canada.

Methods

Applying the test-negative design to linked provincial data, we estimated vaccine effectiveness against infection (irrespective of symptoms or severity) caused by Omicron or Delta between November 22 and December 19, 2021. We included individuals who had received at least 2 COVID-19 vaccine doses (with at least 1 mRNA vaccine dose for the primary series) and used multivariable logistic regression to estimate the effectiveness of two or three doses by time since the latest dose.

Results

We included 3,442 Omicron-positive cases, 9,201 Delta-positive cases, and 471,545 test-negative controls. After 2 doses of COVID-19 vaccine, vaccine effectiveness against Delta infection declined steadily over time but recovered to 93% (95%CI, 92-94%) ≥7 days after receiving an mRNA vaccine for the third dose. In contrast, receipt of 2 doses of COVID-19 vaccines was not protective against Omicron. Vaccine effectiveness against Omicron was 37% (95%CI, 19-50%) ≥7 days after receiving an mRNA vaccine for the third dose.

Conclusions

Two doses of COVID-19 vaccines are unlikely to protect against infection by Omicron. A third dose provides some protection in the immediate term, but substantially less than against Delta. Our results may be confounded by behaviours that we were unable to account for in our analyses. Further research is needed to examine protection against severe outcomes.
...
Funding Statement

This work was supported by the Canadian Immunization Research Network (CIRN) through a grant from the Public Health Agency of Canada and the Canadian Institutes of Health Research (CNF 151944). This project was also supported by funding from the Public Health Agency of Canada, through the Vaccine Surveillance Reference Group and the COVID-19 Immunity Task Force.
...
https://www.medrxiv.org/content/10.1101/2021.12.30.21268565v1
 
Omicron much weaker coronavirus variant than Delta, new study says — but some still urge caution


Alexander Nazaryan
Senior White House Correspondent
Wed, January 12, 2022, 12:51 PM·


WASHINGTON — The Omicron variant of the coronavirus is much less likely to cause hospitalization and death than the earlier Delta variant, a study released by the Centers for Disease Control and Prevention finds, confirming to a dramatic degree predictions some virologists have been making since the now dominant variant first appeared in Southern Africa.

The findings provided “key insight” into how the newest variant operates, CDC Director Dr. Rochelle Walensky said as she introduced the data, which came from a study of both Omicron and Delta infections throughout Southern California. The study found that, as compared to the Delta variant, Omicron resulted in a 91 percent drop in the risk of death, while the risk of hospitalization was halved. For those who did require hospitalization from Omicron, risk of being admitted to an intensive care unit — signaling more serious disease — was reduced by three-fourths.
038ffd50-73d1-11ec-a67f-6db2ff291049

CDC

Omicron infection is “associated with substantially reduced risk of severe clinical endpoints and shorter durations of hospital stay” compared to Delta, the authors found.
...
https://news.yahoo.com/omicron-much...aysbut-some-still-urge-caution-185123453.html
 
As we are beginning to get some useful data on the current VOC this may be a good time to review what we know.
Case counts are rocketing (nearly 3 times any previous wave), and showing no signs of slowing, as the graph below shows.

Click image for larger version  Name:	cov jan 2022.JPG Views:	1 Size:	168.5 KB ID:	935203


There is some, very tentative, evidence that it may be less clinically severe but it is doubtful that this will be enough to stop a flood of hospitalisation and probably deaths. Even if the hoped for drop in virulence significantly reduces the severity, on a case by case basis, the far higher case loads will negate that advantage. Looking at the graph there has not been enough time between the start of the current exponential case growth (the last 3 weeks) to see how that plays out in terms of the deaths due to the lag time of about two weeks for hospitalisations and a month for fatalities.

Omicron definitely has a significant fitness advantage over the other variants but it is very hard to compare with Alpha and Delta, which also rapidly established themselves, as the population's immune profiles have changed so much.
The graph below shows how quickly Alpha (red), Delta (greens) and Omicron (purple) established themselves and then got supplanted. I have used the UK data as they do the most case sequencing and are well globally connected.

Click image for larger version  Name:	covar UK.JPG Views:	1 Size:	43.5 KB ID:	935204


What data there is comes from early case data in South Africa which shows lower, or at least slower, hospitalisations than delta and very different demographic profiles. The age, sex, comorbidities and O[SUB]2[/SUB] need are all very different. (compare column 4 to the earlier VOCs. N.B. also that this is a smaller data set so the confidence limits will be larger).

Click image for larger version  Name:	SA data.JPG Views:	1 Size:	277.3 KB ID:	935206


The next bit of useful data comes from https://www.medrxiv.org/content/10.1....27.21268278v1 which basically shows that at least part of Omicron's fitness advantage comes from immune evasion but a booster vaccine dose helps reduce this. It, along with other data, shows Omicron has a shorter incubation period.

There is also good evidence that Omicron cause less sever symptoms in mice and hamster models with less replication in the lung but high replication in the nose. As usually with animal models it is difficult to say if this has any relevance in humans.


My guess would be that it is a bit milder but very fit. This is good if it reduces morbidity but probably also bad if it leaves more mild and asymptomatic cases shedding and accounting for its explosive growth. I would be very cautious for a while in your contacts with others - distance, wear a mask and, if you can, get vaccinated and boosted. I think our health care services are going to have a hard time coping over the next few months and will need all of us to reduce our risk as much as we can.


The top graph is from the current WHO sitrep
https://www.who.int/docs/default-sou...&download=true

The variants tables can be found here
https://covariants.org/per-country

The SA data
https://jamanetwork.com/journals/jam...rticle/2787776

The mouse/hamster data
https://pubmed.ncbi.nlm.nih.gov/34981044/
 

Attachments

  • SA data.webp
    SA data.webp
    131.5 KB · Views: 0
UK -

Endemic Covid: Is the pandemic entering its endgame?


James Gallagher
Health and science correspondent
@JamesTGallagheron Twitter

Published 2 days ago

...
"We're almost there, it is now the beginning of the end, at least in the UK," Prof Julian Hiscox, chairman in infection and global health at the University of Liverpool, tells me. "I think life in 2022 will be almost back to before the pandemic."
...
There will be people - mostly the old and vulnerable - who will die from endemic Covid. So there is still a decision to be made about how we live alongside it.

"If you're willing to tolerate zero deaths from Covid, then we're facing a whole raft of restrictions and it's not game over," Prof Hiscox explains.

But, he says, "In a bad flu season, 200-300 die a day over winter and nobody wears a mask or socially distances, that's perhaps a right line to draw in the sand."

Lockdowns and restrictions on mass gatherings will not come back and mass testing for Covid will end this year, he expects.

The near certainty is there will be booster vaccines for the vulnerable come the autumn in order to top up their protection through winter.

"We need to accept the fact that our flu season is also going to be a coronavirus season, and that is going to be a challenge for us," says Dr Groppelli.

However, it is still uncertain how bad winters will be as the people who die from flu and Covid tend to be the same. As one scientist put it, "You can't die twice."
...
https://www.bbc.co.uk/news/health-59970281
 
Back
Top Bottom